UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Advanced drug delivery reviews, ISSN 0169-409X, 09/2012, Volume 64, Issue 12, pp. 1277 - 1291
rhBMPs | Regenerative medicine | Bone fracture | Bone tissue engineering | Drug delivery | Spinal surgery | Oral surgery | RhBMPs | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Recombinant Proteins - therapeutic use | Tissue Engineering - methods | United States | Humans | Bone Regeneration | Drug Approval | Recombinant Proteins - administration & dosage | Drug Delivery Systems | Tissue Scaffolds - chemistry | Animals | Bone Morphogenetic Protein 2 - administration & dosage | Bone Morphogenetic Protein 2 - therapeutic use | Bone and Bones - metabolism | Bone Morphogenetic Protein 7 - administration & dosage | Bone Morphogenetic Protein 7 - therapeutic use | United States Food and Drug Administration | Bone morphogenetic proteins | Usage | Fractures | Tissue engineering | Index Medicus | Bone (long) | oral surgery | bone tissue engineering | regenerative medicine | bone fracture | spinal surgery | drug delivery
Journal Article
Annals of internal medicine, ISSN 0003-4819, 06/2013, Volume 158, Issue 12, pp. 877 - 889
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Orthopedic surgery | Medical sciences | Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases | Disability Evaluation | Recombinant Proteins - therapeutic use | Spinal Fusion - methods | Intervertebral Disc Degeneration - surgery | Humans | Treatment Outcome | Recombinant Proteins - adverse effects | Incidence | Bone Morphogenetic Protein 2 - adverse effects | Pain, Postoperative - prevention & control | Time Factors | Transforming Growth Factor beta - therapeutic use | Bone Morphogenetic Protein 2 - therapeutic use | Ilium - transplantation | Transforming Growth Factor beta - adverse effects | Neoplasms - epidemiology | Physiological aspects | Bone morphogenetic proteins | Genetic aspects | Research | Health aspects | Spinal fusion | Proteins | Surgical outcomes | Patient safety | Back surgery | Morphology | Effectiveness studies | Index Medicus | Abridged Index Medicus
Journal Article
Journal of controlled release, ISSN 0168-3659, 06/2012, Volume 160, Issue 3, pp. 676 - 684
Titanium | Apatite | Bone | Bone morphogenic protein-2 | Nanocomplex | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Cell Line | Gene Expression | Cell Proliferation | Nanoparticles - chemistry | Calcium - metabolism | Osteoblasts - drug effects | Alkaline Phosphatase - metabolism | Osteocalcin - genetics | Titanium - chemistry | Recombinant Proteins - chemistry | Titanium - administration & dosage | Bone Morphogenetic Protein 2 - chemistry | Durapatite - chemistry | Recombinant Proteins - administration & dosage | Particle Size | Animals | Bone Morphogenetic Protein 2 - administration & dosage | Collagen Type I - genetics | Durapatite - administration & dosage | Mice | Nanoparticles - administration & dosage | Osteoblasts - metabolism | Delayed-Action Preparations | Hydrogen-Ion Concentration | Phosphates | Phosphate minerals | Phosphatases | Phosphate rock | Hydroxylapatite | Bone morphogenetic proteins | Gene expression | Index Medicus
Journal Article
The spine journal, ISSN 1529-9430, 2014, Volume 14, Issue 3, pp. 552 - 559
Orthopedics | rhBMP-2 | Bone morphogenetic protein | Radiculitis | Complications | Spine | Retrograde ejaculation | Ectopic bone | Osteolysis | Fusion | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Radiculopathy - epidemiology | Recombinant Proteins - therapeutic use | Spinal Fusion - methods | Hematoma - epidemiology | Humans | Risk Factors | Ossification, Heterotopic - etiology | Hematoma - etiology | Recombinant Proteins - adverse effects | Spinal Fusion - adverse effects | Bone Morphogenetic Protein 2 - adverse effects | Dose-Response Relationship, Drug | Cervical Vertebrae - surgery | Ossification, Heterotopic - epidemiology | Radiculopathy - etiology | Lumbar Vertebrae - surgery | Transforming Growth Factor beta - therapeutic use | Bone Morphogenetic Protein 2 - therapeutic use | Transforming Growth Factor beta - adverse effects | Bone morphogenetic proteins | Usage | Surgery | Index Medicus
Journal Article
ACS applied materials & interfaces, ISSN 1944-8244, 02/2020, Volume 12, Issue 6, pp. 6840 - 6851
Research | Science & Technology - Other Topics | Materials Science | Nanoscience & Nanotechnology | Technology | Materials Science, Multidisciplinary | Science & Technology | Nanoparticles - chemistry | Humans | Calcium - administration & dosage | Bone Morphogenetic Protein 2 - chemistry | Delayed-Action Preparations - chemistry | Craniofacial Abnormalities - physiopathology | Transforming Growth Factor beta - chemistry | Calcium - chemistry | Delayed-Action Preparations - administration & dosage | Bone Morphogenetic Protein 2 - administration & dosage | Bone Morphogenetic Protein 2 - metabolism | Gelatin - chemistry | Recombinant Proteins - metabolism | Bone Morphogenetic Protein 2 - genetics | Bone Regeneration - drug effects | Osteogenesis - drug effects | Rats | Recombinant Proteins - chemistry | Craniofacial Abnormalities - drug therapy | Recombinant Proteins - genetics | Cell Adhesion - drug effects | Rats, Sprague-Dawley | Recombinant Proteins - administration & dosage | Silicon - administration & dosage | Delayed-Action Preparations - metabolism | Animals | Transforming Growth Factor beta - genetics | Transforming Growth Factor beta - administration & dosage | Periosteum - physiopathology | Drug Delivery Systems - methods | Periosteum - drug effects | Silicon - chemistry | Transforming Growth Factor beta - metabolism | Hydrogels - chemistry | Index Medicus
Journal Article
The spine journal, ISSN 1529-9430, 2011, Volume 11, Issue 6, pp. 568 - 576
Orthopedics | rhBMP-2 | BMP-binding peptide | Soft-tissue edema | rhBMP-7 | MIPAV | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Inflammation - chemically induced | Bone Morphogenetic Protein 7 - adverse effects | Inflammation - pathology | Humans | Peptide Fragments - administration & dosage | Rats, Inbred Lew | Surgical Sponges - adverse effects | Rats | Male | Recombinant Proteins - adverse effects | Recombinant Proteins - administration & dosage | Bone Morphogenetic Protein 2 - adverse effects | Magnetic Resonance Imaging | Animals | Bone Morphogenetic Protein 2 - administration & dosage | Transforming Growth Factor beta - administration & dosage | Transforming Growth Factor beta - adverse effects | Peptide Fragments - adverse effects | Bone Morphogenetic Protein 7 - administration & dosage | Disease Models, Animal | Subcutaneous Tissue - drug effects | Subcutaneous Tissue - pathology | Medical colleges | Bone morphogenetic proteins | Inflammation | Orthopedic surgery | Peptides | Collagen | Index Medicus
Journal Article
BMC musculoskeletal disorders, ISSN 1471-2474, 07/2018, Volume 19, Issue 1, pp. 261 - 261
Animal model | Bone morphogenetic protein 2 | Delayed osseous union | Rat | Biomechanical testing | Osteitis | Micro-CT | Bone morphogenetic protein 7 | Life Sciences & Biomedicine | Orthopedics | Rheumatology | Science & Technology | Staphylococcal Infections - drug therapy | Rats | Treatment Outcome | Random Allocation | Osteitis - diagnostic imaging | Rats, Sprague-Dawley | Staphylococcal Infections - diagnostic imaging | Animals | Bone Morphogenetic Protein 2 - administration & dosage | Time Factors | Fracture Healing - physiology | Female | Fractures, Bone - diagnostic imaging | Osteitis - drug therapy | Staphylococcus aureus - drug effects | Bone Morphogenetic Protein 7 - administration & dosage | Fractures, Bone - drug therapy | Disease Models, Animal | Care and treatment | Bacterial infections | Analysis | Rattus | Bone morphogenetic proteins | Models | Research | Health aspects | Callus | Chronic infection | Infections | Nonunion | Defects | Proteins | Inoculation | Bone biomaterials | Computed tomography | Tibia | Surgery | Rodents | Bones | Bacteria | Statistical analysis | Mechanical properties | Bone healing | Trauma | Biomechanics | Fractures | Antibiotics | Index Medicus
Journal Article